Site Search
Search Results
ACS CAN Proposal For Regulatory Safe Harbor for Financial Support of Patients on Trials
In response to an annual request from the Department of Health and Human Services (HHS), ACS CAN has proposed a safe harbor from the Anti-Kickback Statute that would allow trial sponsors to provide financial support to trial participants to offset non-medical costs. ACS CAN Proposal For Regulatory Safe Harbor for Financial Support of Patients on Trials ...
ACS CAN Comments on March-In Rights Framework
In response to a request from the National Institute of Starndards and Technology (NIST), ACS CAN has offered comments on the use of march-in rights to address drug costs. ACS CAN Comments on March-In Rights Framework ...
Survivor Views on Artificial Intelligence and FDA Medical Product Reviews
Overview The American Cancer Society Cancer Action Network (ACS CAN) empowers advocates across the country to make their voices heard and influence evidence-based public policy change, as well as legislative and regulatory solutions that will reduce the cancer burden. As part of this effort, ACS CAN deploys surveys to better understand cancer patient and survivor experiences and perspectives, through our Survivor Views ... Key Findings Eighty percent of cancer patients and survivors agree that the industries making FDA-regulated products should provide some of the cost of FDA’s public health oversight Cancer patients and survivors mirror the American public in their hesitancy to embrace AI, with 51% ...
Priority Issue
State
Policy Issue
- (-) Remove Research, Funding and Drug Development filter Research, Funding and Drug Development